Jackson Square Partners’s Novo Nordisk NVO Stock Holding History

Jackson Square Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,278,954	Closed	-$276M	–	86
2016 Q3	$276M	Sell	13,278,954 -1,921,808	-13%	-$47.6M	1.24%	27
2016 Q2	$409M	Sell	15,200,762 -4,718,988	-24%	-$129M	1.72%	24
2016 Q1	$540M	Sell	19,919,750 -747,752	-4%	-$20M	2.17%	20
2015 Q4	$600M	Buy	20,667,502 +504,836	+3%	+$14M	2.22%	21
2015 Q3	$547M	Sell	20,162,666 -3,027,424	-13%	-$85.7M	2.5%	19
2015 Q2	$635M	Sell	23,190,090 -11,952	-0.1%	-$336K	2.43%	18
2015 Q1	$619M	Buy	23,202,042 +1,515,594	+7%	+$34.9M	2.37%	17
2014 Q4	$459M	Sell	21,686,448 -523,292	-2%	-$11.7M	1.81%	23
2014 Q3	$529M	Sell	22,209,740 -1,472,386	-6%	-$33.9M	2.23%	21
2014 Q2	$547M	Buy	+23,682,126	New	+$523M	2.13%	21

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Jackson Square Partners's NVO Position: Q4 2016 in Review

Jackson Square Partners sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 13,278,954 shares — an estimated $276M sold.

Jackson Square Partners first reported a position in NVO in Q2 2014 and held it in 10 quarters. The position peaked at $635M in Q2 2015. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

Jackson Square Partners reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
Jackson Square Partners sold 13,278,954 Novo Nordisk shares in Q4 2016, an estimated $276M.
Jackson Square Partners first reported a position in Novo Nordisk in Q2 2014 and held it in 10 quarters.
Jackson Square Partners's Novo Nordisk position peaked at $635M in Q2 2015.
483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Jackson Square Partners's 13F filing for Q4 2016, filed 13 Feb 2017.